| # | % | |||||
|---|---|---|---|---|---|---|
| 1 | SPDR S&P 500 ETF TR | 100,000 | 22,353,000 | 23.95% | Put | |
| 2 | ANI PHARMACEUTICALS INC COM | 150,000 | 9,093,000 | 9.74% | ||
| 3 | PFIZER INC | 250,000 | 8,120,000 | 8.70% | ||
| 4 | NOVELION THERAPEUTICS INC | 831,440 | 7,001,000 | 7.50% | ||
| 5 | DEPOMED INC | 350,000 | 6,307,000 | 6.76% | ||
| 6 | Albany Molecular | 302,400 | 5,673,000 | 6.08% | ||
| 7 | GILEAD SCIENCES INC | 75,000 | 5,371,000 | 5.75% | ||
| 8 | DEPOMED INC | 250,000 | 4,505,000 | 4.83% | Call | |
| 9 | GILEAD SCIENCES INC | 60,000 | 4,297,000 | 4.60% | Call | |
| 10 | AMGEN INC | 25,000 | 3,655,000 | 3.92% | ||
| 11 | ALLERGAN PLC | 15,000 | 3,150,000 | 3.37% | ||
| 12 | CRYOLIFE INC | 150,000 | 2,873,000 | 3.08% | ||
| 13 | TEVA PHARMACEUTICAL INDS LTD | 75,000 | 2,719,000 | 2.91% | ||
| 14 | ARALEZ PHARMACEUTICALS INC | 575,000 | 2,536,000 | 2.72% | ||
| 15 | PROSHARES TR | 50,000 | 1,750,000 | 1.87% | Call | |
| 16 | PROSHARES TRUST II VIX SHORT TERM FUTURES ETF | 75,000 | 1,595,000 | 1.71% | Call | |
| 17 | AMARIN CORP PLC | 450,000 | 1,386,000 | 1.48% | ||
| 18 | Sunesis Pharmaceuticals, Inc. | 150,000 | 543,000 | 0.58% | Call | |
| 19 | ZOGENIX INC | 31,850 | 387,000 | 0.41% | ||
| 20 | FIBROCELL SCIENCE INC | 47,769 | 30,000 | 0.03% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0000919574-17-001128, filed 2017.02.10).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
